The chondrosarcoma market is witnessing pivotal advancements driven by increased research focus and emerging therapeutics targeting this rare bone cancer. With significant R&D investments and evolving treatment modalities, market dynamics continue to align with strategic industry growth and innovation.Market Size and OverviewThe chondrosarcoma market is estimated to be valued at USD 1028.5...